Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease

Published:2017-05-19 Issue:1 Volume:15 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Karlas Thomas,Weise Lara,Kuhn Stephanie,Krenzien Felix,Mehdorn Matthias,Petroff David,Linder Nicolas,Schaudinn Alexander,Busse Harald,Keim Volker,Pratschke Johann,Wiegand Johannes,Splith Katrin,Schmelzle Moritz

Funder

Federal Ministry of Education and Research (BMBF), Germany

German Research Foundation (DFG) and the University of Leipzig

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-017-1208-6.pdf

Reference42 articles.

1. EASL-EASD-EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.

2. Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13:643–54.

3. Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, Hultcrantz R. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547–54.

4. Bedossa P. Histological assessment of NAFLD. Dig Dis Sci. 2016;61:1348–55.

5. Dyson JK, McPherson S, Anstee QM. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. J Clin Pathol. 2013;66:1033–45.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder;Current Drug Therapy;2024-02

2. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease;Metabolites;2023-10-29

3. Liquid Liver Biopsy for Disease Diagnosis and Prognosis;Journal of Clinical and Translational Hepatology;2023-07-27

4. Discrimination of dyslipidemia types with ATR-FTIR spectroscopy and chemometrics associated with multivariate analysis of the lipid profile, anthropometric, and pro-inflammatory biomarkers;Clinica Chimica Acta;2023-02

5. The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH;International Journal of Molecular Sciences;2023-01-24